Artykuły w czasopismach na temat „Human ovarian carcinoma cells”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Human ovarian carcinoma cells”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Wu, Guang-Jer. "METCAM/MUC18 Decreases the Malignant Propensity of Human Ovarian Carcinoma Cells." International Journal of Molecular Sciences 19, no. 10 (2018): 2976. http://dx.doi.org/10.3390/ijms19102976.
Pełny tekst źródłaImai, Atsushi, Tsukasa Ohno, Kyoko Takahashi, Tatsuro Furui, and Teruhiko Tamaya. "Lack of Evidence for Aromatase Expression in Human Ovarian Epithelial Carcinoma." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 31, no. 1 (1994): 65–71. http://dx.doi.org/10.1177/000456329403100111.
Pełny tekst źródłaSidell, N., and I. R. Horowitz. "Reduced connexin 43 mRNA levels in human ovarian carcinoma." Journal of Clinical Oncology 24, no. 18_suppl (2006): 15071. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.15071.
Pełny tekst źródłaZhang, Li, Po Ding, Hongcheng Lv, et al. "Number of Polyploid Giant Cancer Cells and Expression of EZH2 Are Associated with VM Formation and Tumor Grade in Human Ovarian Tumor." BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/903542.
Pełny tekst źródłaFISHMAN, David A., Alicia KEARNS, Susan LARSH, Jan J. ENGHILD, and M. Sharon STACK. "Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment." Biochemical Journal 341, no. 3 (1999): 765–69. http://dx.doi.org/10.1042/bj3410765.
Pełny tekst źródłaKoon, E. C., P. C. Ma, R. Salgia, et al. "Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion." International Journal of Gynecologic Cancer 18, no. 5 (2008): 976–84. http://dx.doi.org/10.1111/j.1525-1438.2007.01135.x.
Pełny tekst źródłaZhang, W., N. Gan, and J. Zhou. "Immunohistochemical Investigation of the Correlation between LIM Kinase 1 Expression and Development and Progression of Human Ovarian Carcinoma." Journal of International Medical Research 40, no. 3 (2012): 1067–73. http://dx.doi.org/10.1177/147323001204000325.
Pełny tekst źródłaNahar, Begum Afrin, Rama Saha, Chhanda Das, and Gourishankar Kamilya. "Immunohistochemical expression of human epididymis 4 in ovarian malignancy." International Journal of Research in Medical Sciences 7, no. 12 (2019): 4493. http://dx.doi.org/10.18203/2320-6012.ijrms20195506.
Pełny tekst źródłaTassi, R. A., E. Bignotti, M. Falchetti, et al. "Claudin-7 expression in human epithelial ovarian cancer." International Journal of Gynecologic Cancer 18, no. 6 (2008): 1262–71. http://dx.doi.org/10.1111/j.1525-1438.2008.01194.x.
Pełny tekst źródłaImai, Atsushi, Tsukasa Ohno, Kazuhiro Ohsuye, and Teruhiko Tamaya. "Expression of Gonadotropin-Releasing Hormone Receptor in Human Epithelial Ovarian Carcinoma." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 31, no. 6 (1994): 550–55. http://dx.doi.org/10.1177/000456329403100604.
Pełny tekst źródłaLim, Whasun, Wooyoung Jeong, and Gwonhwa Song. "Coumestrol suppresses proliferation of ES2 human epithelial ovarian cancer cells." Journal of Endocrinology 228, no. 3 (2015): 149–60. http://dx.doi.org/10.1530/joe-15-0418.
Pełny tekst źródłaHussein, Usama Khamis, Asmaa Gamal Ahmed, Won Ku Choi, et al. "SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients." Biomolecules 11, no. 3 (2021): 405. http://dx.doi.org/10.3390/biom11030405.
Pełny tekst źródłaChan, Thomas C. K. "Calcium-independent growth of human ovarian carcinoma cells." Journal of Cellular Physiology 141, no. 3 (1989): 461–66. http://dx.doi.org/10.1002/jcp.1041410303.
Pełny tekst źródłaRieppi, Monica, Veronica Vergani, Carmen Gatto, et al. "Mesothelial cells induce the motility of human ovarian carcinoma cells." International Journal of Cancer 80, no. 2 (1999): 303–7. http://dx.doi.org/10.1002/(sici)1097-0215(19990118)80:2<303::aid-ijc21>3.0.co;2-w.
Pełny tekst źródłaQian, H. N., G. Z. Liu, S. J. Cao, J. Feng та X. Ye. "The experimental study of ovarian carcinoma vaccine modified by human B7-1 and IFN-γ genes". International Journal of Gynecologic Cancer 12, № 1 (2002): 80–85. http://dx.doi.org/10.1136/ijgc-00009577-200201000-00013.
Pełny tekst źródłaKalli, Kimberly R., Oluwole I. Falowo, Laurie K. Bale, Michael A. Zschunke, Patrick C. Roche, and Cheryl A. Conover. "Functional Insulin Receptors on Human Epithelial Ovarian Carcinoma Cells: Implications for IGF-II Mitogenic Signaling." Endocrinology 143, no. 9 (2002): 3259–67. http://dx.doi.org/10.1210/en.2001-211408.
Pełny tekst źródłaZhou, Qiang, Minghua Deng, and Jianping Gong. "The role of long non-coding RNAs in human carcinoma." International Surgery Journal 7, no. 11 (2020): 3861. http://dx.doi.org/10.18203/2349-2902.isj20204711.
Pełny tekst źródłaPettinari, Riccardo, Fabio Marchetti, Claudio Pettinari, et al. "Organometallic rhodium(iii) and iridium(iii) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands." Dalton Transactions 44, no. 47 (2015): 20523–31. http://dx.doi.org/10.1039/c5dt03037d.
Pełny tekst źródłaJavid, F. A., and S. Afshinjavid. "The effect of fluoxetine on human ovarian carcinoma cells." Clinical Therapeutics 37, no. 8 (2015): e35. http://dx.doi.org/10.1016/j.clinthera.2015.05.109.
Pełny tekst źródłaRao, Yang, Wenwen Zhang, Dan Li, Xiao Li, Yaomei Ma, and Pengpeng Qu. "Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in Ovarian Cancer by Reducing Smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis." Contrast Media & Molecular Imaging 2022 (August 16, 2022): 1–9. http://dx.doi.org/10.1155/2022/1032557.
Pełny tekst źródłaChung, Yuan-Chiang, Li-Cheng Lu, Ming-Hsiu Tsai, et al. "The Inhibitory Effect of Ellagic Acid on Cell Growth of Ovarian Carcinoma Cells." Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–12. http://dx.doi.org/10.1155/2013/306705.
Pełny tekst źródłaSurowiak, P., M. DrĄG, V. Materna, et al. "Expression of aminopeptidase N/CD13 in human ovarian cancers." International Journal of Gynecologic Cancer 16, no. 5 (2006): 1783–88. http://dx.doi.org/10.1136/ijgc-00009577-200609000-00010.
Pełny tekst źródłaKatz, Yeshayahu, Gilad Ben-Baruch, Yoel Kloog, Joseph Menczer, and Moshe Gavish. "Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries." Clinical Science 78, no. 2 (1990): 155–58. http://dx.doi.org/10.1042/cs0780155.
Pełny tekst źródłaMa, Jun, Jie Yang, Chao Wang, et al. "Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation." BioMed Research International 2014 (2014): 1–8. http://dx.doi.org/10.1155/2014/107671.
Pełny tekst źródłaGUO, H. F., J. FENG, G. LIU, et al. "Establishment and characterization of a human ovarian sarcomatoid carcinoma cell line BUPH: OVSC." International Journal of Gynecologic Cancer 15, no. 5 (2005): 856–65. http://dx.doi.org/10.1136/ijgc-00009577-200509000-00023.
Pełny tekst źródłaKurrasch, R. H., A. V. Rutherford, M. E. Rick, et al. "Characterization of a monoclonal antibody, OVB1, which binds to a unique determinant in human ovarian carcinomas and myeloid cells." Journal of Histochemistry & Cytochemistry 37, no. 1 (1989): 57–67. http://dx.doi.org/10.1177/37.1.2461982.
Pełny tekst źródłaReader, Jocelyn C., Cong Fan, Eleanor Claire-Higgins Ory, et al. "Microtentacle Formation in Ovarian Carcinoma." Cancers 14, no. 3 (2022): 800. http://dx.doi.org/10.3390/cancers14030800.
Pełny tekst źródłaHolm, Jan, Steen Ingemann Hansen, Mimi Høier-Madsen, and Poul-Erik Helkjær. "A Folate Binding Protein in Ascitic Fluid, Serum and Ovarian Tissue of Patients with Ovarian Adenocarcinoma Immunoreacts with Antibodies Against Human Milk Folate Binding Protein." Bioscience Reports 18, no. 2 (1998): 49–57. http://dx.doi.org/10.1023/a:1020174325204.
Pełny tekst źródłaBrown, Geoffrey. "Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells." International Journal of Molecular Sciences 24, no. 3 (2023): 2373. http://dx.doi.org/10.3390/ijms24032373.
Pełny tekst źródłaWei, Shuang, Ilona Kryczek, Linhua Zou, et al. "Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma." Cancer Research 65, no. 12 (2005): 5020–26. http://dx.doi.org/10.1158/0008-5472.can-04-4043.
Pełny tekst źródłaWalton, James W., Jasmine M. Cross, Tina Riedel, and Paul J. Dyson. "Perfluorinated HDAC inhibitors as selective anticancer agents." Organic & Biomolecular Chemistry 15, no. 43 (2017): 9186–90. http://dx.doi.org/10.1039/c7ob02339a.
Pełny tekst źródłaPrinetti, Alessandro, Danilo Millimaggi, Sandra D'Ascenzo, et al. "Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells." Biochemical Journal 395, no. 2 (2006): 311–18. http://dx.doi.org/10.1042/bj20051184.
Pełny tekst źródłaBae, Hyocheol, Gwonhwa Song, and Whasun Lim. "Stigmasterol Causes Ovarian Cancer Cell Apoptosis by Inducing Endoplasmic Reticulum and Mitochondrial Dysfunction." Pharmaceutics 12, no. 6 (2020): 488. http://dx.doi.org/10.3390/pharmaceutics12060488.
Pełny tekst źródłaGao, Ying, Junfeng Yin, Youying Tu, and Yi Chen. "Theaflavin-3,3′-Digallate Suppresses Human Ovarian Carcinoma OVCAR-3 Cells by Regulating the Checkpoint Kinase 2 and p27 kip1 Pathways." Molecules 24, no. 4 (2019): 673. http://dx.doi.org/10.3390/molecules24040673.
Pełny tekst źródłaAdham, Sirin A. I., Ifat Sher, and Brenda L. Coomber. "Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells." Laboratory Investigation 90, no. 5 (2010): 709–23. http://dx.doi.org/10.1038/labinvest.2010.52.
Pełny tekst źródłaRose, Stephen L., Matthew P. Fitzgerald, Natalie O. White, et al. "Epigenetic regulation of maspin expression in human ovarian carcinoma cells." Gynecologic Oncology 102, no. 2 (2006): 319–24. http://dx.doi.org/10.1016/j.ygyno.2005.12.025.
Pełny tekst źródłaAndrews, Paul A., Michael P. Murphy, and Stephen B. Howell. "Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells." European Journal of Cancer and Clinical Oncology 25, no. 4 (1989): 619–25. http://dx.doi.org/10.1016/0277-5379(89)90195-8.
Pełny tekst źródłaTong, Lu, Wenjiao Cao, Jun Sheng, et al. "RDM1 plays an oncogenic role in human ovarian carcinoma cells." Artificial Cells, Nanomedicine, and Biotechnology 48, no. 1 (2020): 885–92. http://dx.doi.org/10.1080/21691401.2020.1770267.
Pełny tekst źródłaCanaday, Daniel, Ming Zeng, George Cerniglia, and Craig W. Stevens. "2018 Radiation improves gene tranfer into human ovarian carcinoma cells." International Journal of Radiation Oncology*Biology*Physics 39, no. 2 (1997): 249. http://dx.doi.org/10.1016/s0360-3016(97)80787-0.
Pełny tekst źródłaTeyssier, Jean Raymond, Jean Bénard, Daniel Ferre, Jacqueline Da Silva, and Laurence Renaud. "Drug-related chromosomal changes in chemoresistant human ovarian carcinoma cells." Cancer Genetics and Cytogenetics 39, no. 1 (1989): 35–43. http://dx.doi.org/10.1016/0165-4608(89)90227-6.
Pełny tekst źródłaFernstrom, Martha J., Lucas D. Koffler, George Abou-Rjaily, Paul D. Boucher, Donna S. Shewach, and Randall J. Ruch. "Neoplastic Reversal of Human Ovarian Carcinoma Cells Transfected with Connexin43." Experimental and Molecular Pathology 73, no. 1 (2002): 54–60. http://dx.doi.org/10.1006/exmp.2002.2436.
Pełny tekst źródłaYaşayan, Gökçen, Oya Orun, Pınar Mega Tiber, Veronika Rožman, and Sevgi Koçyiğit Sevinç. "The interactions of human ovarian cancer cells and nanotextured surfaces: cell attachment, viability and apoptosis studies." RSC Advances 9, no. 45 (2019): 25957–66. http://dx.doi.org/10.1039/c9ra03783g.
Pełny tekst źródłaVetro, Maria, Barbara Costa, Giulia Donvito, et al. "Anionic glycolipids related to glucuronosyldiacylglycerol inhibit protein kinase Akt." Organic & Biomolecular Chemistry 13, no. 4 (2015): 1091–99. http://dx.doi.org/10.1039/c4ob01602e.
Pełny tekst źródłaWatanabe, Megumi, Motoki Matsuura, Tatsuya Sato, et al. "Fatty Acid Metabolism Regulators Have Pivotal Roles in the Pathogenesis of Ovarian Carcinoma." International Journal of Molecular Sciences 26, no. 10 (2025): 4794. https://doi.org/10.3390/ijms26104794.
Pełny tekst źródłaKutlvasr, K., K. Bukovjan, and R. Kodet. "Bilateral low grade serous adenocarcinoma of the ovaries in a badger (Meles meles L.) and its association with a borderline serous ovarian tumour: a case report." Veterinární Medicína 59, No. 1 (2014): 44–50. http://dx.doi.org/10.17221/7245-vetmed.
Pełny tekst źródłaNakazato, T., T. Kanuma, T. Tamura, L. S. Faried, H. Aoki, and T. Minegishi. "Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer." International Journal of Gynecologic Cancer 17, no. 2 (2007): 426–32. http://dx.doi.org/10.1111/j.1525-1438.2007.00815.x.
Pełny tekst źródłaSu, Xiu-Zhen, Ran Chen, Cai-Bing Wang, Xi-Lin Ouyang, Yan Jiang, and Ming-Yi Zhu. "Astaxanthin Combine with Human Serum Albumin to Abrogate Cell Proliferation, Migration, and Drug-resistant in Human Ovarian Carcinoma SKOV3 Cells." Anti-Cancer Agents in Medicinal Chemistry 19, no. 6 (2019): 792–801. http://dx.doi.org/10.2174/1871520619666190225123003.
Pełny tekst źródłaWang, Chia-Woei, Chien-Kai Wang, Yu-Jia Chang, et al. "Preclinical Evaluation on the Tumor Suppression Efficiency and Combination Drug Effects of Fermented Wheat Germ Extract in Human Ovarian Carcinoma Cells." Evidence-Based Complementary and Alternative Medicine 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/570785.
Pełny tekst źródłaLi, Yi, Ming Xiao, and Fangchun Guo. "The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis." Tumor Biology 39, no. 5 (2017): 101042831770550. http://dx.doi.org/10.1177/1010428317705508.
Pełny tekst źródłaZhang, S., Q. D. Lin, and W. Di. "Suppression of human ovarian carcinoma metastasis by the metastasis‐suppressor gene,BRMS1." International Journal of Gynecologic Cancer 16, no. 2 (2006): 522–31. http://dx.doi.org/10.1136/ijgc-00009577-200603000-00010.
Pełny tekst źródła